The effectiveness of xylocaine spray in upper gastrointestinal endoscopy
The effect of 10% xylocaine spray compared to a placebo on ease of endoscopy and hemodynamic changes in patients admitted for upper gastrointestinal endoscopy under deep sedation with total intravenous anesthesia
Chang Gung Memorial Hospital
150 participants
Dec 25, 2010
Interventional
Conditions
Summary
The use of topical pharyngeal anesthesia has long been controversial among the anesthetists and no evidence has well supported the use of the spray. The use of lidocaine spray is not without adverse effects, which include aspiration pneumonia, methemoglobinemia and anaphylaxis. Most of the patients undergo endoscopies under general anesthesia and theoretically should not require pharngeal spray to suppress pharyngeal reflexes during the procedure. The aim of the study is determine whether the use of the spray is necessary in patients under deep sedation/general anesthesia. Deep sedation is achieved by total intravenous anesthesia (TIVA) with propofol.
Eligibility
Inclusion Criteria3
- All participants who sign the consent and agreement form
- All participants who are admitted for upper gastrointestinal endoscopy under general anesthesia with total intravenous anesthesia
- All participants who are between the age of 20 and 69
Exclusion Criteria4
- young age <20 years; old age >69 years
- participants who are reported to have allergic reaction to the anesthetic agents used in the study (lidocaine)
- pregnant women or who are breastfeeding
- participants who are deemed to have significant higher risk if enrolled in the study (eg severe obstructive sleep apnea)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients are randomly assigned to have 10% lidocaine spray (approximately 30mg) or normal saline in their throat on arrival, approximately 3 minutes before upper gastrointestinal endoscopy.
Locations(2)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000143921